Related Experiment Video
Updated: Jul 16, 2025
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024
Borderline phyllodes tumour of the breast with eosinophilic inclusion bodies: Case report and molecular sequencing
Ngoc My Lam1, Jean-Christophe Noël2, Nicky d'Haene2
1Department of Pathology, CurePath (Chirec Institute-Brussels, CHU Tivoli-La Louviere), Rue de Borfilet 12A, 6040 Charleroi, Belgium.
Introduction And Importance:
The presence of eosinophilic inclusion bodies in the breast is very rare and fewer than 20 cases were described in the literature. Herein we report the first case of borderline phyllodes tumour associated with this kind of cells. To the best of our knowledge, this is also the first time that a molecular sequencing is made targeting the stroma cells with inclusion bodies.
Case Presentation:
A 33-yr-old woman presented a large mass in the right breast. Imaging techniques by mammogram and ultrasonographic examination were performed. After multidisciplinary approach, a breast conserving surgery has been decided. Microscopic analysis, immunohistochemical stains and molecular tests were performed on the lesion. The proposed diagnosis is borderline phyllodes tumour with eosinophilic inclusion bodies.
Clinical Discussion:
Inclusion bodies are typically found in the infantile digital fibromatosis. Finding them in extradigital fibromatosis is rare. Their signification is still unclear. Some studies suggest a disturbance in the metabolism of proliferating myofibroblasts.
Conclusion:
The presence of inclusion bodies in breast tumour do not seem to have a prognosis impact. It might be interesting to perform others molecular tests on lesions with eosinophilic inclusion bodies to discover potential mutations.
